Yale Program in Addiction Medicine physicians and advanced practice providers prevent, diagnose, and treat substance use disorders and related harms. Our program, founded on over 30 years of pioneering research designed to integrate addiction treatment into general medical settings, is internationally recognized for leadership in the field and innovative approaches to care. Our clinicians are experienced in treating opioid, alcohol, tobacco, and other substance use disorders and in providing medications and behavioral therapy for substance use treatment. Our clinicians have training in a wide range of areas in medicine including internal medicine, primary care, emergency medicine, pediatrics, infectious diseases, psychiatry, pulmonary and critical care medicine. They are experienced in providing treatment for substance use alongside pregnancy and care for other co-occurring conditions such as pain, Hepatitis C, HIV, bacterial infections, and mental health diagnoses.
Yale Program in Addiction Medicine clinicians see patients in community health centers, primary care clinics, infectious disease clinics, the emergency department, and in the hospital.
We emphasize a patient-centered approach to care and will work with patients and their families to identify a treatment plan that best supports the patient’s needs and goals. Our clinicians meet patients where they are—whether they are new to treatment, returning to treatment, or exploring ways to reduce risk associated with substance use. Our dedicated clinicians are experienced in treating the full spectrum of substance use from intermittent use to severe substance use disorder. We use evidence-based treatment strategies to care for patients throughout the often relapsing-remitting nature of the disease of addiction and are supported by a large community of experts in the field working to develop and make available innovative, effective treatment options. In collaboration with our many community-based and institutional partners, we offer a robust network of care options to ensure appropriate support for our patients at every stage of treatment.
Yale School of Medicine is a teaching institution. As such, patient care teams may include physician fellows, residents, advanced practice trainees, and or medical students being trained by our program in addiction medicine.
The Yale Program in Addiction Medicine houses a robust research portfolio focused on advancing innovative treatments and improving the quality and efficacy of care for our patients. We are internationally recognized for our scholarly contributions to the field, particularly with respect to implementation and evaluation of medications for substance use treatment in primary care clinics, infectious disease clinics, the emergency department, and in the hospital, as well as comprehensive training and education of the next generation of addiction medicine providers.
Our faculty and collaborators form an interdisciplinary team representing internal medicine, primary care, harm reduction, pain medicine, psychiatry, psychology, emergency medicine, pulmonology, geriatrics, palliative care, infectious disease, pediatrics, public health, law, and more.